PIOGLITAZONE ACCORD
15MG TBL NOB 84
| Maximum ex-factory price/Ex-factory price ? | 1248,72 CZK |
|---|---|
| Legal basis of maximum ex-factory price/ex-factory price ? | Maximum ex-factory price announced under the law. |
Informace o základní úhradě
| Core reimbursement from health insurance ? | 736,38 CZK |
|---|---|
| Maximum reimbursement from health insurance ? | 1059,47 CZK |
| Legal basis of reimbursement from health insurance ? | Reimbursement set by the law. |
| Indication restriction of reimbursement ? | Deriváty thiazolidindionů jsou indikovány v další volbě po neúspěšné terapii metforminem nebo kombinaci se sulfonylureou u pacientů s diabetem 2. typu a obezitou (BMI vyšší než 30 kg/m2) a s vyjádřenou insulinovou rezistencí. Léčba je ukončena, pokud nedojde do 6 měsíců k prokazatelnému zlepšení kompenzace diabetu léčbou s glitazony (pokles hodnoty HbA1c alespoň o 10%). |
| Prescribing doctor's specialisation ? | Diabetology |
| Reporting limit ? | L: Product subject to prescription restriction may be prescribed for reimbursement by a health insurer only by a doctor with specialist capacity, stating the professional field in the prescription restriction, who has concluded an agreement on the provision of the relevant health service with the health insurer in respect of the specialist capacity, or another doctor under written authority of the Specialist Doctor. |
| Rough price for the final consumer ? | 1698,40 CZK |
| Rough payment for the final consumer (for 1 prescribed package dispensed) ? | 638.93 CZK |
| Eligible extra payment ? | 140,49 CZK |
| Eligible extra payment for individuals aged 65 and older ? | 140,49 CZK |
cz